Autopsy report · NCT01283763

Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia

“poor recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 4 months before it started.
• Ran for about 4 years 8 months before it stopped.
• 95 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Medical University of Vienna

Sponsor type

University, hospital or other

Conditions

Cervical Intraepithelial Neoplasia

Interventions

Topical Imiquimod; Conization

Participants

95

Sites

1

Countries

Austria

Trials that died the same way

• Pilot RCT Evaluating a One Stop Vein Clinic
  “Very poor recruitment” (95% match in meaning)
• Prospective Evaluation of Quality of Life in Patients With Acute Colonic Diverticular Disease
  “poor recruitment status” (93% match in meaning)
• Intrauterine Device Insertion Pain Management
  “Inadequate recruitment” (92% match in meaning)
• Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients
  “Low recruitment” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.